Loading insider details...
Beta
Latest Form 4 (Sep 15, 2026): Sale of 1,000 CYTK shares, $72.1K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 15, 2026 | CYTOKINETICS INC (CYTK) | Sale | 1,000 | $72.1K |
| Sep 11, 2026 | CYTOKINETICS INC (CYTK) | Sale | 1,000 | $74.7K |
| May 27, 2026 | CYTOKINETICS INC (CYTK) | Grant/Award | 2,851 | n/a |
| Jan 13, 2026 | Zymeworks Inc. (ZYME) | Grant/Award | 11,500 | n/a |
| Aug 13, 2025 | Zymeworks Inc. (ZYME) | Grant/Award | 62,000 | n/a |
| May 14, 2025 | CYTOKINETICS INC (CYTK) | Grant/Award | 7,333 | n/a |
| Feb 11, 2025 | CYTOKINETICS INC (CYTK) | Grant/Award | 25,538 | n/a |
| Feb 6, 2024 | REGENERON PHARMACEUTICALS, INC. (REGN) | Exercise/Conversion | 400 | $151.6K |
| Feb 2, 2024 | REGENERON PHARMACEUTICALS, INC. (REGN) | Exercise/Conversion | 400 | $151.6K |
| Jan 25, 2024 | REGENERON PHARMACEUTICALS, INC. (REGN) | Exercise/Conversion | 1,100 | $416.9K |